All In Biotech

Drug Trial Radar · NCT06723405

Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis

A Randomized, Double-blind, Placebo-controlled, Proof-of-concept Study of EVO301 in Adults With Atopic Dermatitis

Last checked: Nov 19, 2026Latest source record: Dec 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

71

Actual

Start

Feb 13, 2025

Primary completion

Nov 17, 2025

Study completion Nov 17, 2025

Sponsor

Lead sponsor
Evommune, Inc.Industry
Sponsor type
Industry
First posted
Dec 9, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2a efficacy and safety study of EVO301 for the treatment of adults with atopic dermatitis.

Conditions

  • Atopic Dermatitis (AD)
  • Eczema
  • Eczema Atopic Dermatitis

Interventions

  • EVO301Biological

    Intravenous EVO301

  • PlaceboBiological

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Eczema Area and Severity Index (EASI)Time frame: 12 weeks

Locations

12 sites in 2 countries. Site status is shown where the registry gives one.

  • Cornerstone Dermatology

    Coorparoo, Australia

  • Momentum Clinical Research Darlinghurst

    Darlinghurst, Australia

  • Pacific Clinical Research Network (PCRN) Auckland

    Auckland, New Zealand

  • Optimal Clinical Trials North

    Auckland, New Zealand

  • Optimal Clinical Trials

    Auckland, New Zealand

  • Pacific Clinical Research Network (PCRN) Christchurch

    Christchurch, New Zealand

  • Momentum Clinical Research Dunedin

    Dunedin, New Zealand

  • Clinical Trials New Zealand Ltd

    Hamilton, New Zealand

  • Momentum Clinical Research Lower Hutt

    Hutt Central, New Zealand

  • Pacific Clinical Research Network (PCRN) Tasman

    Nelson, New Zealand

  • Momentum Clinical Research Kapiti

    Paraparaumu, New Zealand

  • Momentum Clinical Research Pukekohe

    Pukekohe, New Zealand

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.